PLIANT THERAPEUTICS INC (PLRX) Stock Cash Flow
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -219.51M | -210.30M | -161.34M | -123.32M | -97.26M | |||
| Depreciation Amortization | 2.06M | 2.13M | 1.84M | 1.82M | 1.54M | |||
| Change In Working Capital | 122.00K | 9.09M | 1.25M | 4.22M | 6.92M | |||
| Interest Paid | 2.84M | 2.62M | 1.15M | 620.00K | N/A | |||
| Other non cash items | 43.24M | 43.59M | 41.88M | 22.65M | 13.37M | |||
| OPERATING CASH FLOW | -174.10M | -155.50M | -116.36M | -94.63M | -75.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.62M | -3.85M | -921.00K | -1.76M | -1.95M | |||
| Other Investing Activity | 152.53M | 144.19M | -126.09M | -148.44M | 75.65M | |||
| INVESTING CASH FLOW | 149.91M | 140.34M | -127.01M | -150.20M | 73.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.00K | 19.91M | 0.00 | 9.85M | N/A | |||
| Stock Issued/Repurchased | 1.83M | 3.21M | 275.25M | 217.56M | 2.98M | |||
| Other Financing Activity | N/A | 0.00 | -847.00K | -560.00K | -460.00K | |||
| FINANCING CASH FLOW | 1.83M | 23.12M | 274.40M | 226.85M | 2.53M | |||
| CHANGE IN CASH | -22.36M | 7.95M | 31.03M | -17.98M | 790.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -174.10M | -155.50M | -116.36M | -94.63M | -75.44M | |||
| Capital Expenditure | -2.62M | -3.85M | -921.00K | -1.76M | -1.95M | |||
| FREE CASH FLOW | -176.71M | -159.35M | -117.28M | -96.39M | -77.39M | |||
All data in USD